Oklo Inc.
$ 45.81
-6.22%
13 Jul - close price
- Market Cap 8,499,460,000 USD
- Current Price $ 45.81
- High / Low $ 48.12 / 45.07
- Stock P/E N/A
- Book Value 15.18
- EPS -0.84
- Next Earning Report 2026-08-10
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.07 %
- ROE -0.09 %
- 52 Week High 193.84
- 52 Week Low 44.88
About
Oklo Inc. designs and develops fission power plants to provide reliable and commercial-scale energy to customers in the United States. The company is headquartered in Santa Clara, California.
Analyst Target Price
$88.63
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-05-12 | 2026-03-17 | 2025-11-11 | 2025-08-11 | 2025-05-13 | 2025-03-24 | 2024-11-14 | 2024-08-13 | 2024-05-08 | 2024-03-29 | 2023-11-15 | 2023-08-11 |
| Reported EPS | None | -0.27 | -0.2 | -0.18 | -0.07 | -0.0896 | -0.08 | -5.17 | -0.0652 | 0.0546 | 0.0378 | 0.0591 |
| Estimated EPS | -0.1837 | -0.16 | -0.12 | -0.11 | -0.11 | -0.0665 | -0.07 | -0.06 | -0.07 | None | None | None |
| Surprise | 0 | -0.11 | -0.08 | -0.07 | 0.04 | -0.0231 | -0.01 | -5.11 | 0.0048 | 0 | 0 | 0 |
| Surprise Percentage | None% | -68.75% | -66.6667% | -63.6364% | 36.3636% | -34.7368% | -14.2857% | -8516.6667% | 6.8571% | None% | None% | None% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-08-10 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | -0.17 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: OKLO
2026-07-14 08:30:53
Cathie Wood's ARK Invest has increased its holdings in nuclear energy companies Oklo Inc. (OKLO) and X-energy Inc. (XE), with shares of both companies rising premarket. ARK Autonomous Technology & Robotics ETF (ARKQ) purchased 100,854 shares of OKLO, while ARK Invest bought an additional 545,453 shares of XE across multiple ETFs. This investment comes amidst renewed interest in nuclear energy, driven by the demands of AI infrastructure and supportive policy measures, despite significant declines in both companies' stock prices since the beginning of the year.
2026-07-14 07:57:53
Cathie Wood is adjusting her portfolio by increasing investments in nuclear energy companies like X-Energy and Oklo, and gene therapy pioneers such as Prime Medicine and Beam Therapeutics. She is also focusing on AI-driven drug discovery withRecursion Pharmaceuticals and digital securitization with Securitize. Concurrently, she is trimming positions in certain tech stocks like Advanced Micro Devices (AMD) and biotechnology companies like Personalis, indicating a strategic shift towards energy revolution and frontier medical technologies.
2026-07-14 05:41:53
Oklo Inc. has received U.S. Department of Energy approval for its Groves Isotope Test Reactor, advancing its efforts in domestic medical and industrial isotope production. This approval strengthens Oklo's broader investment narrative, reinforcing its potential to monetize its reactor and isotope pipeline. However, the company still faces significant execution and financing risks across its complex, pre-revenue projects.
2026-07-13 16:41:53
Oklo Inc. (NYSE:OKLO) shares dropped 5.5% on Monday, bringing their total decline to 76% from a 52-week high, yet the company is still valued at $5.4 billion without revenue after accounting for its significant cash reserves. The nuclear energy firm has $2.54 billion in cash and marketable securities against $64.9 million in liabilities, meaning its pre-revenue business is valued by the market at approximately $5.39 billion. Despite the stock plunge, its strong balance sheet and upcoming milestones like the Groves isotope test reactor and potential power purchase agreements are key factors for investors.
2026-07-13 10:29:00
Oklo's Groves Isotope Test Reactor in Texas received final safety approval from the U.S. Department of Energy, a significant step toward its targeted first criticality in July 2026. This approval, part of a federal initiative to accelerate advanced reactor deployment, has given some momentum to Oklo's stock, despite its previous volatility and current pre-revenue status. The reactor aims to establish a domestic supply chain for critical isotopes used in various applications, while analysts maintain cautious optimism for the company's future.
2026-07-13 08:41:53
InvestingPro's Fair Value models accurately predicted a significant decline in Oklo Inc. (NYSE:OKLO) stock, identifying it as overvalued by 41.96% in September 2025. Despite a surge in nuclear energy stocks, Oklo, a pre-revenue company, saw its shares drop by 47.79% to $48.85 from $95.83. This case demonstrates how InvestingPro's comprehensive valuation methodology helps investors avoid overpriced assets and find better exit points in volatile markets.
